Lori M. Reilly is chief operating officer at the Pharmaceutical Research and Manufacturers of America (PhRMA), providing executive level management, leadership and strategic direction for the organization. In this role, Ms. Reilly oversees PhRMA’s advocacy activities, including its federal, state and international government affairs and alliance development work. Ms. Reilly works across PhRMA to develop and advocate for practical policy solutions that will lower costs for patients.
Ms. Reilly, named by The Hill as a top lobbyist in 2018 and 2019, has a long record of working with members of Congress on a bipartisan basis and collaborating with stakeholders across the health care industry. Ms. Reilly is a frequent presenter on industry-related issues, including testifying before Congress on multiple occasions.
Ms. Reilly has nearly two decades of experience at PhRMA; prior to her current role, Ms. Reilly was the executive vice president of policy, research and membership at PhRMA, leading the development and implementation of legislative, regulatory and political strategies to advance policies that encourage patient access and medical innovation. She has also served as counsel at the U.S. House of Representatives Committee on Commerce and was Counsel to a member of the House Ways and Means Committee.
Ms. Reilly received a B.A. in political science from the University of Nebraska-Lincoln where she graduated with honors, and a J.D. from the University of Nebraska College of Law. She currently resides in Alexandria, Virginia with her husband and their four children.